IDHIRA：一项关于ivosidenib治疗R132突变型晚期胆管癌患者的前瞻性观察研究。
IDHIRA: a prospective, observational study on ivosidenib in patients with R132-mutated advanced cholangiocarcinoma.
作者信息
Michl Marlies, Hagemeyer Nora, Looß Marion, Grebhardt Sina, Ringwald Kai, Potthoff Karin
机构信息
Hämato-Onkologische Schwerpunktpraxis Dr. Michl, München, Germany.
iOMEDICO, Freiburg im Breisgau, Germany.
出版信息
Future Oncol. 2025 Apr;21(9):1057-1064. doi: 10.1080/14796694.2025.2470609. Epub 2025 Mar 3.
Abstract
www.clinicaltrials.gov identifier is NCT06607302.
摘要
美国国立医学图书馆临床试验注册中心标识符为NCT06607302。
Zotero 插件